BME100 f2015:Group4 8amL2

From OpenWetWare
Jump to: navigation, search
Owwnotebook icon.png BME 100 Fall 2015 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help
BME494 Asu logo.png


OUR TEAM

Name: Kendra Starkel
Name: Anastasia Wyatt
Name: Austen Bennett
Name: Drew Higgins
Name: Michael Vietz
Name: Bhavna Ramesh

LAB 2 WRITE-UP

Descriptive Statistics

Human Study
Treatment.jpg
Rat Study
Treatment2.jpg




Results

Human Test
Humandata.jpg


Rat Test
BME100Rattest.jpg




Analysis

Human Test
An ANOVA test for the humans was used because there were more than two groups in the study. P-Value:1.4E-16
Post-hoc Tests
BME100-PostHocData.jpg

Rat Test
A t-test for the rats was used because there were only two groups in the study. P-Value:0.8674035 pg/mL
The P-Value was greater than 0.05 causing there to be no significance between the two data sets.



Summary/Discussion

There was no significant differences between the rats meaning that the drug LPS had no effect on their inflammation levels.
However, in the human study each dosage presented a significant difference meaning that the drug LPS presented an effect on the inflammation levels of humans. As the dosage increased the inflammation levels increased drastically proving the effectiveness of the drug. The minimum amount of LPS needed to produce an effect on the inflammation levels was between 5-10mg.